1: Zhang HS, Liu YR, Liu SH. Ethanol foam: a novel type of foam sclerosant for treating venous malformations. Front Neurol. 2024 Aug 7;15:1431723. doi: 10.3389/fneur.2024.1431723. 2: Granja López J, Estebas Armas C, Lorenzo Dieguez M, Puertas Muñoz I, De Celis Ruiz E, Rigual R, Fernández-Fournier M, Torres Iglesias G, Sánchez Velasco S, Tallón Barranco A, Rogozina O, Ramírez E, González-Muñoz M, Lacruz Ballester L. Neurological manifestations of immune origin after COVID-19 vaccination: retrospective case study. Front Pharmacol. 2024 Aug 8;15:1376474. doi: 10.3389/fphar.2024.1376474. 3: Patel V, Mehta T, Shah J, Soni K. Quality by design driven development of lipid nanoparticles for cutaneous targeting: a preliminary approach. Drug Deliv Transl Res. 2024 Aug 15. doi: 10.1007/s13346-024-01685-9. Epub ahead of print.
合成参考文献
参考文献:10.1097/01.olq.0000114655.79109.ed 摘要:Rohan LC, Ratner D, McCullough K, Hiller SL, Gupta P. Measurement of anti-HIV activity of marketed vaginal products and excipients using a PBMC-based in vitro assay. Sex Transm Dis. 2004 Mar;31(3):143–8. doi: 10.1097/01.olq.0000114655.79109.ed.